Research
Bausch + Lomb unveils 2025 state of dry eye survey results
Building on 2024 findings, latest results indicate a need for more patient education to dispel ongoing misconceptions surrounding dry eye.
Products
Bausch + Lomb launches two new eye drops to Blink portfolio
Now available at most U.S. retailers, the latest additions to this specialty product line includes Blink Nourish Lubricating and Blink Boost Lubricating eye drops.
Products
Bausch + Lomb launches PF LUMIFY redness reliever drops
Newest preservative-free, OTC formulation of low-dose brimonidine tartrate is available in single-use vials to relieve eye redness due to minor ocular irritations.
Products
Bausch + Lomb launches ortho-k lens fitting system
The Arise cloud-based platform syncs directly with diagnostic tools to create a customized lens design for myopia treatment in mere seconds—without the need for a fitting set.
Business
Bausch + Lomb may be acquiring InflammX Therapeutics
Option agreement indicates B+L intends to purchase the biotech company and its orally-administered therapeutic under clinical investigation for retinal diseases.
Business
Bausch + Lomb adds to glaucoma and GA pipeline with two deals
Latest developments involve the acquisition of WhiteCap Biosciences and its GA candidate, as well as a partnership with RNAi-focused City Therapeutics.
Events
Bausch + Lomb launches second annual glaucoma awareness campaign
As part of a partnership with the Glaucoma Research Foundation, this month-long initiative honors January as Glaucoma Awareness Month.
Business
Bausch + Lomb purchases Elios Vision
Acquisition includes the ELIOS procedure, an excimer laser-based and implant-free MIGS technology performed during cataract surgery for glaucoma treatment.
Products
Bausch + Lomb demos new Opal online ordering platform
E-commerce platform lets patients directly order from a customized catalog of products while minimizing and simplifying clinical practices’ administrative workload.
Business
Bausch + Lomb names leading ophthalmologist as strategic medical advisor
Industry veteran Cathleen McCabe, MD, will consult on the company’s expanding product portfolio and serve as liaison to the global ECP community.
Products
FDA approves Bausch + Lomb's en Vista Envy IOL
Offering a continuous range of vision with excellent dysphotopsia tolerance, the lens will be initially available on a limited basis.
Products
Bausch + Lomb launches new digital ordering marketplace
The Opal e-commerce platform enables patients to directly order contact lens products from a customized catalog, freeing up clinical practice staff time and resources.
Business
Bausch + Lomb acquires Trukera Medical
Purchase of the former TearLab Corporation includes the ScoutPro Osmolarity System, a point-of-care portable device for osmolarity testing.
Research
Bausch + Lomb reports national dry eye data, launches awareness tool
State of the Dry Eye survey finds 70% of patients lack knowledge and education of the disease.
Products
Bausch + Lomb to launch INFUSE for Astigmatism SiHy lenses in the US
Latest one-day silicone hydrogel lens addition maintains 96% of moisture for 16 hours.
Products
Bausch + Lomb launches Blink NutriTears for dry eye
Newest addition to the Blink product line targets root cause of disease; clinically proven to provide symptom relief in as little as 2 weeks.
Products
Bausch + Lomb's enVista Envy IOL secures Canadian approval
Acceptance marks first global regulatory approval for the new lens; company notes FDA approval is pending.
Products
Bausch + Lomb's Zenlens ECHO scleral lens launches in the US
Latest installment is designed as a non-prosthetic, custom scleral contact lens technology designed to fit a wide variety of corneal shapes and sizes.
Products
Bausch + Lomb reports statistically significant data on novel dry eye supplement
Randomized study suggests Blink NutriTears may restore tear film homeostasis by addressing DED’s key root causes.
Events